Hrt Financial LP Celldex Therapeutics, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$22.61 - $40.65 $189,064 - $339,915	-8,362 Reduced 38.7%	13,243 $525,000
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $549,847 - $809,323	21,605 New	21,605 $594,000
Q4 2022 Feb 10, 2023	BUY	$27.78 - $45.38 $1.94 Million - $3.17 Million	69,796 New	69,796 $3.11 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $566,260 - $805,548	-20,487 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $730,976 - $1.15 Million	20,487 New	20,487 $791,000
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $2.28 Million - $3.9 Million	-110,306 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $151,975 - $280,765	9,387 Added 9.3%	110,306 $2.27 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.51 Million - $2.3 Million	100,919 New	100,919 $1.77 Million

197

66M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.05B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.